MRNA
Moderna IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$19.70B
P/E Ratio
—
EPS
$-8.14
Beta
1.03
52W High
$59.55
52W Low
$22.28
50-Day MA
$49.54
200-Day MA
$38.42
Dividend Yield
—
Profit Margin
-143.50%
Forward P/E
23.04
PEG Ratio
0.00
About Moderna Inc
Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.
Fundamentals
| Revenue (TTM) | $2.23B |
| Gross Profit (TTM) | $-1.56B |
| EBITDA | $-2.30B |
| Operating Margin | -131.10% |
| Return on Equity | -36.60% |
| Return on Assets | -13.10% |
| Revenue/Share (TTM) | $5.69 |
| Book Value | $18.66 |
| Price-to-Book | 2.66 |
| Price-to-Sales (TTM) | 8.90 |
| EV/Revenue | 7.16 |
| EV/EBITDA | 4.64 |
| Quarterly Earnings Growth (YoY) | -85.10% |
| Quarterly Revenue Growth (YoY) | 260.20% |
| Shares Outstanding | $396.79M |
| Float | $370.08M |
| % Insiders | 7.31% |
| % Institutions | 78.94% |
Historical Volatility
HV 10-Day
79.20%
HV 20-Day
62.35%
HV 30-Day
65.73%
HV 60-Day
57.12%
HV Rank
59.5%
Volatility is currently expanding
Analyst Ratings
Consensus ($43.30 target)
2
Strong Buy2
Buy16
Hold1
Sell3
Strong SellMore HEALTHCARE Stocks
Data last updated: 6/13/2026